The MEK inhibitor trametinib for the treatment of advanced melanoma

Douglas B. Johnson*, Megan L. Hames, Jeffrey A. Sosman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The MEK inhibitor trametinib for the treatment of advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences